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All organisms are exposed to numerous stress factors, 
which include harmful xenobiotics. The diversity of these 
compounds is enormous, thus in the course of evolution 
diverse biological defense mechanisms at various levels 
of organization have developed. One of them engages 
an evolutionarily conserved family of transporters from 
the ABC superfamily, found in most species – from bac-
teria to humans. An important example of such a trans-
porter is the breast cancer resistance protein (BCRP/
ABCG2), a typical integral membrane protein. It plays a 
key role in the absorption, distribution and elimination 
of a wide variety of xenobiotics, including drugs used in 
chemotherapy, and is involved in multidrug resistance. It 
also protects against phototoxic chlorophyll derivatives 
of dietary origin. BCRP is a hemitransporter which con-
sists of one transmembrane domain, made of six alpha-
helices forming a characteristic pore structure, and one 
ATP-binding domain, which provides the energy from 
ATP hydrolysis, required for active transport of the sub-
strates. The isolation of BCRP is still not an easy task, be-
cause its insolubility in water and the presence of mem-
brane rafts pose serious methodological and technical 
challenges during the purification. The aim of this study 
was to optimize the methods for detection and isolation 
of BCRP-enriched fractions obtained from animal tissue 
samples. In this report we describe an optimization of 
isolation of a BCRP-enriched membrane fraction, which 
is suitable for further protein quantitative and qualita-
tive analysis using the molecular biology tools.
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INTRODUCTION
Living organisms are equipped with very well-function-
ing systems of stress management, which involve, among 
others, a superfamily of ATP binding cassette (ABC) 
transporters, responsible for removal of harmful metabo-
lites from inside the body and protection against exog-
enous xenobiotics. The ABC transporters have a unique 
structure comprising the large multispanning transmem-
brane and ATP binding domains. Among such trans-
porters, the breast cancer resistance protein (BCRP or 
ABCG2) is perhaps the best characterized one. Its tissue 
localization reflects its important role in protecting the 
body from toxic substances. It is found in the stem cells, 
the blood-brain barrier, placenta, and in the barrier tissues, 
which form the first line of defense, i.e. intestines, lungs, 
liver or kidneys (Maliepaard et al., 2001; Telbisz et al., 
2007). BCRP is a 72 kDa transmembrane protein, which 
consists of a single nucleotide binding domain (NBD) and 
a single membrane spanning domain (MSD), made of 6 
transmembrane α-helices (Ni et al., 2010). BCRP usually 
functions as a homodimer (Kage et al., 2002). Cholesterol 
and bile acids are important regulators of BCRP activity 
(Telbisz et al., 2013), which implies a demand for a cau-
tious handling during its extraction from biological mate-
rial and further functional analysis.
Chlorophyll metabolites, derived from plant photosyn-
thetic pigments consumed by herbivores (including hu-
mans), are a dangerous group of xenobiotics due to their 
high phototoxicity (Kotkowiak et al., 2017). Their accu-
mulation in the body may lead to lethal consequences 
and there must exist an efficient system of elimination of 
such compounds. This is performed by BCRP, the lack 
of which is associated with a high photosensitivity of the 
skin in animals fed on plant food (Jonker et al., 2002). 
BCRP also participates in the transport of protopor-
phyrin IX (Szafraniec et al., 2014) and its absence caus-
es clinical symptoms similar to that of protoporphyria 
(Jonker et al., 2002; Robey et al., 2004). In an ecophysi-
ological aspect, man and animals may also be exposed 
to undesirable accumulation of toxic metallochlorophyll 
metabolites, derived from plant food produced in soil 
areas contaminated with salts of heavy metals (e.g. Zn, 
Cu, Ni) (Kupper & Kupper, 2006). Metallochlorophylls 
are also used as green food colorants (E140, E141), and 
their photocytotoxicity seems to be overlooked in the 
admissibility test (Watson, 2001). On the other hand, 
due to the aforementioned ability to photosensitize, ex-
cellent light absorption properties and biocompatibility, 
chlorophyllides and other polar chlorophyll and bacteri-
ochlorophyll derivatives are investigated as photosensi-
tizers in photodynamic therapy (Staroń et al., 2015). An 
example of such a photosensitizer is Zn-pheophorbide, 
recently shown to have a high antitumor efficacy in 
animal studies (Jakubowska et al., 2013) or Tookad (Pd-
BChlide), whose strong phototherapeutic properties were 
confirmed in the phase III clinical trials (Azzouzi et al., 
2013).
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The possibility of fast and reliable identification and 
characterization of xenobiotic transporters is crucial in 
the context of interactions between animal organisms 
and Chl-derived xenobiotics (Szczygieł et al., 2008), and 
important also from the viewpoint of multidrug resist-
ance and its prevention in the case of chemotherapeutic 
agents or photosensitizers. There is a growing interest in 
studying BCRP in more advanced models, also using ex-
perimental animals.
There are many reports on the expression, extraction 
and crystallization of the BCRP protein, based on insect 
cells or yeast expression systems (Ozvegy et al., 2001; 
Scharff-Poulsen & Pedersen, 2013), but most of them 
involve complex and tedious protocols. Therefore, there 
is still a need for a simple, robust method for BCRP iso-
lation and detection to facilitate its quantitative and qual-
itative analysis. Here, we present an optimized protocol 
that allows for a quick detection and visualization of 
BCRP in the BCRP-enriched membrane fractions during 
their preparation from ex vivo tissue samples, suitable for 
further analysis via molecular biology tools.
MATERIALS AND METHODS
Animals. Sample collection for tissue analysis. The 
animals used in the present study were obtained from 
the animal breeding facility at the Mossakowski Medi-
cal Research Centre Polish Academy of Sciences, War-
szawa, Poland. Male DBA/2 mice, 2–4 months old were 
kept in community cages, on a standard laboratory diet 
(LaboFeed B from Morawski, Kcynia, Poland), with free 
access to fresh water and a 12 h day/night regime. Be-
fore the experiments, the animals were quarantined and 
acclimatizated for two weeks. Their use for experimental 
purposes was approved by the 1st Local Ethics Com-
mittee for Experiments on Animals at the Jagiellonian 
University in Cracow (permission No. 25/2009, 13/2010 
and 132/2010). After the anesthesia and sections, the tis-
sue and organ samples were collected from the DBA/2 
mice and stored in liquid nitrogen until further analyses.
Histological and immunohistochemical analyses. 
Freshly excised samples of tissues were immersed in a 
cryoprotectant (CryomatrixTM, Thermo Scientific, USA) 
and frozen in liquid nitrogen. The samples were cut into 
4 µm thick slices using a microtome (Leica CM 1100), 
then placed on poly-L-lysine coated microscopic glass-
es, fixed in cold 96% ethanol for 1 min and stored in 
phosphate-buffered saline (PBS) at 4°C. The sections for 
the hematoxylin and eosin (HE) staining were prepared 
according to a standard protocol (Mayer, 1891). For im-
munohistochemical analysis, the slides were kept in PBS 
containing 0.1% Tween (PBS-T) for 5 min and a nonspe-
cific binding was blocked by 1.5 h incubation in a 10% 
skimmed milk in PBS-T. After rinsing in PBS-T (5 min), 
the endogenous avidin sites were blocked by a 10 min 
incubation in egg white solution. After rinsing with dis-
tilled water (3 min), the endogenous peroxidase activ-
ity was blocked by immersing in 3% H2O2 for 15 min. 
Then the slides were incubated with the BXP-53 anti-
body (Sigma-Aldrich, Germany) at a 1:100 dilution for 
1 h at 30°C (the intestines) or 2 h at room temperature 
(the kidneys and the liver). Next, the slides were incu-
bated for 1.5 h at room temperature with a biotinylated 
secondary antibody (biotin mouse anti-rat IgG 1/2a, BD 
Pharmingen) at a 1:200 dilution. The slides were rinsed 
three times with PBS-T, and incubated with streptavidin-
horseradish peroxidase (HRP) for further 30 min. After 
the formation of the avidin–biotin–peroxidase complex 
the slides were rinsed three times with PBS-T, and treat-
ed with 3,3V-diaminobenzidene (DAB, Vector Laborato-
ries, Burlingame, USA) to detect the bound peroxidase. 
The reaction was terminated by rinsing the slides in cold 
tap water. After counterstaining with hematoxylin and 
0.1% ammonia water, the cover slips were mounted us-
ing a water-based adhesive. The negative controls were 
prepared by omission of the primary and secondary an-
tibodies.
Image analysis of tissue slices. The slides were ex-
amined under a light microscope (Nikon Eclipse TS100) 
using a 100× magnification. The images were taken us-
ing a Nikon D7000 camera and a Camera Control Pro 
2 software (Nikon Instruments, Badhoevedorp, Nether-
lands). Image analysis was performed using a freeware 
ImageJ v1.46r (Center for Information Technology Na-
tional Institutes of Health, Maryland, USA, https://im-
agej.nih.gov/ij/).
Protein isolation, quantification and detection. 
The key steps of protein isolation and Western blotting 
detection procedures were verified in a sequence shown 
in Fig. 1.
Several different variants of the isolation procedure 
were tested until satisfactory results were obtained, based 
on the previously described methods in which some pre-
parative steps were modified (Théou et al., 2005; Xu et 
al., 2007). Briefly, the protocol involved the following 
steps: (i) tissue fragmentation and homogenization of 
the samples, (ii) lysis with various buffers and detergents, 
centrifugation to remove insoluble fractions, (iii) deter-
mination of protein concentration, (iv) gel loading, and 
(v) BCRP detection.
These points are described below, along with an in-
dication of the different test variants. At the end of this 
section, there is a comprehensive description of the op-
timized procedure.
(i) Tissue fragmentation. The samples were ex-
cised and fragmented using a scalpel. For isolation, 
10–100 mg tissue portions were taken. After the addi-
tion of lysis buffer, the samples were homogenized us-
ing either a hand-held mechanical homogenizer, a glass 
homogenizer or a mortar, or homogenized with the use 
of metal beads. An additional step of sonication was also 
performed.
(ii) Detergents and lysis buffers. A range of lysis 
buffers containing various mild detergents was tested 
to find the most suitable one. Initially, based on the lit-
erature, the following buffers were used: a 20 mM Tris 
buffer (pH 7.4), containing 150 mM NaCl, 1 mM sodi-
um orthovanadate, 10 mM NaF, 1 mM PMSF, 0.5 µg/ml 
leupeptin, 1 µg/ml pepstatin, 10 KIU/ml aprotinin, and 
1% Triton X-100 (Xu et al., 2007), and a 25 mM Tris 
buffer (pH 7.4) containing 150 mM NaCl, 1 mM EDTA, 
2 mM phenylmethylsulfonyl fluoride, and 1% Triton 
X-100 (Théou et al., 2005). Afterwards, a TNN buffer 
containing 50 mM Tris (pH 7.5), 150 mM NaCl, 0.5% 
NP-40, 0.2 mM sodium orthovanadate, 1mM PMSF and 
protease inhibitors without EDTA was used, in combi-
nation with several detergents, including Tween-20 and 
Brij 58. Finally, a two-step lysis was implemented us-
ing two buffers in order to separate the soluble protein 
fraction from the detergent resistant membrane (DRM) 
fraction, i.e. buffer 1, containing 50 mM Tris-HCl (pH 
7.5), 150 mM NaCl, 1% Brij 58, 1 mM sodium ortho-
vanadate, 1 mM PMSF and protease inhibitors without 
EDTA, and its modification, buffer 2 (lysis buffer for 
membrane rafts), additionally containing 0.5% SDS and 
1% β-mercaptoethanol.
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(iii) Protein quantification. The total protein con-
centration was initially determined using either the Lowry 
assay or the BCA assay, but because of the interference 
with detergents, in particular with SDS, present in lysis 
buffers, it was changed to the Bradford assay (Bradford, 
1976) as the method of choice.
(iv) Optimization of gel loading. Initially, aliquots 
of 50 µg of total protein were loaded per well onto po-
lyacrylamide gels. During the protocol optimization this 
amount was lowered gradually down to 5 µg of protein 
per well, which was sufficient for the accurate detection 
by Western blotting.
(v) Detection method. For protein detection, two 
different HRP-conjugated substrates were tested. First, 
the colorimetric Opti-4CN™ Substrate Kit (BioRad, 
USA) was used; the membranes were incubated for 
30 min in the Opti4CN™ Substrate and washed in 
deionized H2O for 15 min. The visualized membranes 
were dried and photographically documented. Because of 
the low sensitivity of the colorimetric assay, a chemilu-
minescent detection was employed as follows: the mem-
branes were incubated with the LumiGLO Peroxidase 
Chemiluminescent Reagent (Cell Signaling Technology, 
USA) for 1 min and visualized either by using a Chemi-
Doc™ Imaging System (BioRad, USA) or on a film in 
a darkroom (2 min exposure time). The images of the 
blots were processed using the ImageJ software.
Coomassie Blue staining. A standard SDS/PAGE 
was performed using a 20 µg load of protein per well. 
After the separation, the gels were rinsed in a Coomas-
sie Blue solution (0.1% Coomassie Brilliant Blue R-250, 
40% methanol and 10% acetic acid in distilled water) for 
45 min at room temperature and washed with a destain-
ing solution (20% methanol and 10% acetic acid in dis-
tilled water) for 1 h. The destaining solution was ex-
changed every 10 min. The gels were photographed and 
stored in distilled water at 4ºC.
Optimized two-step isolation procedure. The tissue 
samples were dissected using a scalpel, suspended in 500 
μl of ice-cold lysis buffer 1 and homogenized using a 
TH-02 tissue homogenizer (OMNI International, USA). 
The homogenates were centrifuged at 16 000 × g for 25 
min at 4ºC. The supernatants containing soluble proteins 
were collected and transferred to fresh Eppendorf tubes. 
The pellets were suspended in 400 µl of ice-cold lysis 
buffer 2, sonicated on ice 5 times for 15 s and centri-
fuged at 16 000 × g for 10 min at 4ºC. The supernatants 
were collected and stored at –20ºC until further use. The 
total protein concentration in the DRM fraction was de-
termined using the Bradford assay.
Western blotting. Aliquots of 5 μg of DRM frac-
tion obtained from tissue lysates were separated by SDS-
PAGE on a 10% polyacrylamide gel and transferred 
onto nitrocellulose membrane with the use of standard 
wet-tank electrotransfer technique (60 V, 90 min). The 
membranes containing separated proteins were blocked 
in a 5% skimmed milk solution in a Tris-buffered sa-
line containing 0.5% Tween 20 (TBS-T) and incubated 
overnight at 4ºC with the primary BXP-53 rat antibod-
ies against BCRP at 1:200 dilution; the mouse mono-
clonal anti-β-actin antibodies (Sigma Aldrich, Germany) 
at 1:2 000 dilution were used as a reference to maintain 
equal protein loads. The membranes were washed 3×10 
min in TBS-T, incubated for 90 min with the second-
ary HRP-conjugated antibodies (polyclonal rabbit antirat 
against primary ABCG2 antibodies at 1:2500 dilution 
and polyclonal goat antimouse against primary β-actin 
antibodies at 1:1000 dilution; Dako, Denmark), and 
washed again 3 × 10 min in TBST. All steps were con-
ducted at room temperature. After 1 min incubation at 
room temperature with LumiGLO Peroxidase Chemilu-
minescent Reagent, the blots were visualized on a film in 
a darkroom (2 min exposure). A semi-quantitative densi-
tometric analysis of the immunoblots was performed us-
ing the ImageJ software.
RESULTS AND DISCUSSION
Membrane proteins are naturally associated with lipid 
bilayers, and often they are embedded into the mem-
brane rafts. Their analysis is difficult because of high 
hydrophobicity and poor solubility in aqueous solutions. 
The use of detergents, which is crucial in their solubili-
zation, poses difficulties in their extraction, purification 
and structural analyses (Mancia & Love, 2010). Mem-
brane proteins are divided into several classes, which are 
Figure 1. A diagram showing the optimization steps in isolation of BCRP and its detection by Western blotting technique.
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characterized by various types of association with the 
membrane; these include transmembrane proteins, im-
mersed into the lipid bilayer, as well as proteins cova-
lently and noncovalently attached to the membrane. The 
different types of interactions, along with some individ-
ual characteristics of those proteins (such as stability or 
pH dependency) make their isolation particularly intricate 
(Kubicek et al., 2014).
BCRP is an example of a membrane protein with a 
large multispanning domain, residing in detergent insolu-
ble membrane rafts (Hegedus et al., 2015; Storch et al., 
2007), and therefore it is not easily accessible.
BCRP localization
The immunohistochemical analysis shows the pres-
ence of BCRP protein in renal, hepatic, small intestine 
and large intestine cells from DBA/2 mice while it was 
not detected in heart or spleen (Fig. 2). In the kidney, 
BCRP is localized in epithelial cells of nephron tubules, 
in the liver it is present in hepatocytes, and in the small 
and large intestine in epithelial cells of the intestinal villi. 
The analysis based on the use of monoclonal and poly-
clonal antibodies shows the membrane localization of 
BCRP (Diestra et al., 2002; Doyle & Ross, 2003). These 
tissue and cellular localizations of BCRP correlate with 
the functions of the transporter (Maliepaard et al., 2001; 
Fetsch et al., 2006). The transporter is mainly detected in 
cells from organs of secretive functions, such as hepato-
cytes, small intestinal epithelial cells, colon, kidneys and 
lungs, and in the blood brain barrier and placenta (Gut-
mann et al., 2005; Takano et al., 2006).
The immunohistochemical staining allows for the 
visualization of protein expression directly in the tissue, 
because the structure of the organ in the slice remains 
intact during its preservation. IHC is a relatively simple 
but time-consuming method of analysis. It requires some 
experience and although it provides a valuable informa-
tion about the expression of the protein of choice, it 
is not considered to be quantitative, especially for large 
numbers of samples.
In order to detect BCRP in a more quantitative way, 
the Western blotting analysis was done. Various modifi-
cations in both protein isolation and the detection meth-
ods were applied as described under Materials and Meth-
ods, with the aim to achieve the highest yield of the 
DRM fraction and the most sensitive protein visualiza-
tion using this technique. The experiments were carried 
out ex vivo on samples of the DBA/2 mouse tissues and 
the entire membrane protein extraction and detection 
workflow involves several steps, which all underwent op-
timization (Fig. 1).
Tissue fragmentation
During the initial step of mechanical tissue homog-
enization, multiple cycles of freezing and thawing should 
be avoided in order to prevent protein degradation and 
aggregation, which additionally may lead to errors in 
determining its concentration. Therefore, the mechani-
cal treatment of samples should be selected carefully to 
obtain sufficient protein yields (Gorr & Vogel, 2015). 
Several approaches were tested, taking in the considera-
tion the yield of protein and shortening the time of the 
whole procedure to minimize the chances for generating 
artifacts. At first, frozen tissue samples were ground in 
a mortar in liquid nitrogen. Unfortunately, with a large 
number of samples to process, it turned out to be an 
overwhelmingly long step, and the amounts of isolated 
protein were not satisfactory. Similar difficulties were 
met when using a manual Potter homogenizer. It usually 
gives low protein yields, while prolonged isolation time 
increases the number of freeze-thaw cycles, increasing 
the risk of denaturation (Mitchell et al., 2005). Mechani-
cal devices are more efficient, but they may also lead to 
protein denaturation due to the heating or oxidation due 
to the contact with air. In this respect, a short homog-
enization with the use of a handheld electrical homog-
enizer followed by an additional sonication proved to be 
the most effective.
The choice of detergent and lysis buffer
Several lysis buffers dedicated to membrane proteins 
were investigated. BCRP is susceptible to proteolytic deg-
radation and thus a rich set of protease inhibitors must 
be applied during the isolation. It is known that deter-
gent-based extraction gives the highest membrane protein 
yields among other considered methods (Lehner et al., 
2003). Initially, a single-step isolation procedure was used, 
varying only the detergent. The isolation with the use of a 
Figure 2. The immunohistochemical staining of various tissues 
from the DBA/2 mice. 
BCRP (ABCG2) was detected in frozen tissue sections using the 
BXP-53 monoclonal antibody, stained with the anti-mouse HRP-
DAB antibody (brown color indicates the presence of BCRP) and 
counterstained with hematoxylin (blue background). Controls 
were processed without the primary antibody. Scale bar: 5 µm.
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TNN buffer gave insufficient protein yields (not shown). 
Therefore, other lysis buffers were tried and the results 
compared on a single blot, including a TNN buffer, two 
buffers from previously published protocols (Théou et al., 
2005; Xu et al., 2007), and a self-developed one-step mem-
brane lysis buffer, in all cases using the same colorimetric 
detection method. However, none of the tested buffers 
proved effective, while the colorimetric assay turned out 
to be insufficiently specific and not very sensitive. The 
one-step membrane lysis buffer was also tried in combi-
nation with chemiluminescence detection done directly on 
the membrane. However, neither the detection method 
was specific enough nor the isolation itself yielded samples 
of satisfactorily high protein concentrations (not shown).
The following mild detergents were not effective in 
the extraction of BCRP from the membranes: Brij58, 
Triton X100 and NP40. Therefore, an introduction of 
a second extraction step was necessary, with the use of 
a stronger detergent, SDS, which yielded sufficient pro-
tein amounts. As the next optimization stage, a two-step 
method was employed in order to specifically obtain the 
DRM protein fraction.
The results obtained using the one- and two-step iso-
lation protocols are shown in Fig. 3B. In comparison to 
one-step isolation, the protein bands from two-step pro-
tocol were visible and of a good quality. Both fractions 
from the twostep protocol were checked for the BCRP 
content. The fraction obtained in the second step of the 
procedure contained more protein and produced lower 
background, as compared to the first one, suggesting a 
higher purity of the protein.
The lysates obtained with the use of the optimized 
two-step isolation yielded total protein concentrations in 
the range of 1–10 mg/ml. The efficiency of the isolation 
procedure amounts to approximately 0.2 mg of protein 
per 1 mg of the tissue, with the DRM fraction being a 
quarter of that. The densitometric analysis shows that 
the protein fraction obtained by the two-step protocol is 
about five-fold enriched (Fig. 3C) in comparison to the 
most effective one-step protocol.
Another advantage of using a two-step lysis method is 
the partitioning of the proteins; the majority of cytoplas-
mic proteins remain in the supernatant collected in the 
first step. The densitometric analysis confirms that most 
of BCRP is accumulated in the membrane fraction and 
the enrichment factor reaches 15 (Fig. 3C).
To obtain the active transporter using SDS, which dis-
integrates the nuclear membrane, DNAse must be used 
to prevent unwinding of DNA, which may interfere with 
the analysis of protein concentration and with the trans-
Figure 3. The representative results of Western blotting and Coomassie staining (details in the text). 
The lysates were prepared from tissues obtained from in vivo DBA/2 mice. A, B, C: comparison of Coomassie staining (A) and Western 
blotting (B, C) analysis as an evaluation of different protein isolation protocols based on the kidney lysates. Each sample contained ei-
ther 5 µg of total protein (Western blotting) or 20 µg of protein (Coomassie staining). Lane and bar designation: 1 – according to (Xu et 
al., 2007), 2 – according to (Théou et al., 2005), 3 – samples lysed in the TNN buffer, 4 – one step membrane lysis buffer, 5 – two step 
lysis buffer for membrane rafts, supernatant No. 1 (cytoplasmic fraction), 6 – two step lysis buffer for membrane rafts, supernatant No. 2 
(membrane fraction), 7 – BCRP overexpressed in yeast membranes (positive control). The gel after separation was stained with Cooma-
sie blue (A) or transferred to a nitrocellulose membrane and BCRP was analyzed using Western blotting (B, top); β-actin was used as a 
loading control (B, bottom). C: the relative amount of BCRP determined by densitometric analysis of the signals obtained from the mem-
brane in B; normalized to the β-actin level. D, E, F: two step lysis buffer for membrane rafts, DRM protein fraction, 5 µg protein per lane; 
detection on film. D: two different primary antibodies against different BCRP epitopes; Ab 63907 – on the left; BXP-53 – on the right. 
Lane designation: 1–2: liver; 3–4: kidneys. E: evaluation of specificity of the BXP-53 antibody. Lane designation 1–2: kidneys (often serve 
as positive control for BCRP); lane 3: liver; lanes 4–6 (negative control): spleen, muscles, heart F: Blot obtained with the use of the opti-
mized protocol. Lane designation: 1–3: small intestine, 4–6: large intestine, 7–8: liver.
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fer of the samples into the gel. Also to obtain a blotting 
band of pure BCRP, unbound to lipids, special denatur-
ing conditions in sample buffer have to be applied at 
60°C, what counteracts protein aggregation.
Protein quantification and optimization of gel loading
For the determination of the total protein concentra-
tion in the fractions obtained, the Lowry, BCA and Brad-
ford assays have been compared. The former two assays 
were found unreliable due to the interference with deter-
gents and disulfide reducing agents, and also the lipid rafts 
present in the samples were lowering their accuracy. In ef-
fect, the Bradford assay was found the most suitable.
In order to maintain equal protein loads across the gels, 
a loading control in the form of a housekeeping gene is 
usually needed (Gorr & Vogel, 2015). In the present case, 
β-actin seems to be adequate as a positive control. In ad-
dition, the optimization of protein amount is necessary to 
obtain sharp enough bands suitable for further densitomet-
ric analyses of the blots (Taylor & Posch, 2014). The rec-
ommended aliquots of protein loaded onto a gel are usually 
in the range of 25–50 µg, which often is unjustified and 
excessive (Mahmood & Yang, 2012). Indeed, the tests have 
shown that the amount of 5 µg of protein is optimal to ob-
tain clear and distinct bands while avoiding gel overloading.
Detection method
Two types of antibodies against BCRP were tested for 
its detection. The BXP-53 antibody, targeting the BCRP 
epitope localized between the amino acid residues 221 and 
394, gives a much stronger signal than the Ab63907 anti-
body, which recognizes the region between the residues 550 
and 650. This observation suggests that the intracellular re-
gion of the transporter recognized by the former antibody 
is better accessible than the extracellular moiety (Fig. 3D). 
In addition, when using the BXP-53 antibody, in all sam-
ples from kidneys, along with the BCRP band (~72 kDa), 
an extra band of molecular mass of approximately 35 kDa 
was detected (Fig. 3D), similar to the one reported earlier 
(Eldashera et al., 2013; Mao et al., 2004). It was not seen 
when the Ab63907 antibody was used, suggesting that the 
35 kDa peptide might be a specific degradation product of 
BCRP lacking the epitope recognized by this antibody.
Concerning the signal visualization method, the HRP-
based chemiluminescent detection paired with exposure of 
the membrane to a autoradiographic film is by far the most 
sensitive among tested methods; already 1 µg of protein is 
enough to obtain a clearly resolved band (Bass et al., 2017).
To confirm the specificity of our detection method, a 
negative control, i.e. samples of tissues in which BCRP 
is not expressed, was run on a gel in parallel to sam-
ples of tissues with high expression of BCRP (Fig. 3E). 
Sharp BCRP bands were obtained in the case of kidneys 
and liver, while no signal was detected in the heart, mus-
cles or spleen. A negative control Western blotting anal-
ysis with only the secondary antibodies was also done 
on samples from various tissues in order to confirm the 
specificity of the used antibodies and no nonspecific bid-
ing was observed (not shown).
Coomassie staining
SDS/PAGE followed by a Coomassie Brilliant Blue 
staining was run in order to determine the purity of iso-
lated protein mixtures. In the case of liver and kidney, 
there is a clear difference between the lysates originating 
from the 2nd protein fraction obtained with the use of 
the two-step optimized isolation protocol and the other 
methods used (Fig. 3A). Obviously, the protein patterns 
differ across organs, which is understandable considering 
the expression profiles of distant tissues. However, they 
are highly similar between the same organs in lysates 
obtained with the use of all evaluated protocols except 
for the optimized two-step method. Moreover, in the 
latter samples there is a lower number of distinct pro-
tein bands. They are also sharper and of higher density 
compared to the other lysates, suggesting a better over-
all protein purity (Fig. 3A). These results may indicate 
that TNN, one-step and other similar protocols (Xu et 
al., 2007; Théou et al., 2005) yield a mixture of the solu-
ble and membrane proteins, while the present method 
of choice seems more efficient in separating the protein 
fractions.
Optimized two-step procedure
A two-step method was employed in order to ob-
tain the DRM protein fraction, followed by binding of 
a HRP-conjugated secondary antibody and exposure of 
an autoradiographic film. The method gave much higher 
membrane protein yields, which at first lead to the over-
loading of the detection system, improved after apply-
ing lower amounts of the protein. The sensitivity of the 
autoradiographic detection method turned out to be high 
enough to visualize protein samples as low as 1–5 μg.
Figure 3F depicts a representative Western blot im-
age obtained with the use of the optimized protocol, us-
ing the two-step isolation method, i.e. two separate lysis 
buffers and mechanical sample homogenization followed 
by s sonication, and transfer onto a nitrocellulose mem-
brane via a wet-tank technique. The gel was visualized 
with the use of a HRP substrate on an autoradiographic 
film. This procedure ensures consistent and reproducible 
results between experiments.
In order to evaluate the usefulness of the optimized 
protocol in other experimental systems, BCRP isolation 
and detection in tissues originating from other mouse 
strains (C57Bl and SCID) and other species (hamster) 
were performed (not shown). The obtained results con-
firm that it is a versatile procedure, applicable to tissues of 
different origin and in a variety of experimental models.
CONCLUSIONS
The Western blotting technique is a very useful tool 
in molecular biology research; however, it requires a 
thorough understanding of each stage of the procedure. 
It also requires that the methodology used is adapted to 
each individual experimental model, so that the results are 
interpretable and reliable. The mechanical protein isolation 
from the tissue must be carefully selected and, on the oth-
er hand, not to cause protein degradation. The key aspect 
is the choice of a buffer with the appropriate detergent, 
especially in the case of proteins embedded in the mem-
brane rafts. The method of estimating the amount of pro-
tein is also very important. Antibodies must be validated 
using both positive and negative controls to ensure their 
specificity. The detection method should be sensitive and 
adequate to protein concentration.
Membrane proteins, including ABCG2, have proven 
to be very difficult to study due to their relatively hy-
drophobic properties and the lack of stability in aque-
ous solutions. We have applied a step-by-step protocol 
for the isolation and detection of BCRP, which provides 
consistent and reproducible results. The methodology 
described in this paper improves the BCRP extraction 
from tissue samples and allows for further quantitative 
Vol. 64       443Optimized detection of ABCG2 protein by Western blotting analysis
and qualitative analysis of the protein by molecular biol-
ogy tools.
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